Ansana focuses on improving hospital sterilisation processes through its flagship product, SteriWatch. The system monitors and manages sterilisation workflows, aiming to reduce human error, boost efficiency, and ultimately enhance patient safety. By delivering real-time insights, SteriWatch helps hospital staff track instruments and ensure compliance with hygiene standards. Ansana intends to use its newly secured capital to advance product development and expand commercial deployments. Although detailed operating metrics such as revenue or user count were not disclosed, the company positions itself to address a critical need in healthcare operations. Future plans likely include broader market rollout across European healthcare facilities and continued R&D to refine the platform’s feature set.

Total raised

$3M

Funding rounds

2

Latest round

Equity

Latest activity

Sep 2025